Eur Radiol 2016 Mar 04
The diagnostic ability of F-FDG PET/CT for mediastinal lymph node staging using F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer.   
ABSTRACT
OBJECTIVES
To evaluate the clinical implications of lymph node (LN) density on F-FDG PET/CT for mediastinal LN characterization in non-small cell lung cancer (NSCLC).
METHODS
One hundred and fifty-two patients with 271 mediastinal LNs who underwent PET/CT and endobronchial ultrasound-guided transbronchial needle aspiration for staging were enrolled. Maximum standardized uptake value (SUVmax), short axis diameter, LN-to-primary cancer ratio of SUVmax, and median Hounsfield unit (HU) based on CT histogram were correlated to histopathology.
RESULTS
Of 271 nodes, 162 (59.8 %) were malignant. SUVmax, short axis diameter, and LPR of malignant LNs were higher than those of benign nodes. Among malignant LNs, 71.0 % had median HU between 25 and 45, while 78.9 % of benign LNs had values <25 HU or >45 HU. Using a cutoff value of 4.0, SUVmax showed the highest diagnostic ability for detecting malignant LNs with a specificity of 94.5 %, but showing a sensitivity of 70.4 %. Using additional density criteria (median HU 25-45) in LNs with 2.0< SUVmax ≤4.0, the sensitivity increased to 88.3 % with the specificity of 82.6 %.
CONCLUSIONS
LN density is useful for the characterization of LNs with mild F-FDG uptake. The risk of mediastinal LN metastasis in NSCLC patients could be further stratified using both F-FDG uptake and LN density.
KEY POINTS
• SUVmax showed the highest diagnostic ability for detecting malignant LNs. • LN density was useful in characterization of LNs with mild FDG uptake. • SUVmax and LN density together could stratify the risk of LN metastasis.

Related Questions

Would your answer differ based on whether the patient is receiving concurrent chemotherapy? Are there other factors that would influence this decision...